CHAPEL HILL, N.C.--(BUSINESS WIRE)--
POZEN Inc. (POZN), today announced results for the third quarter ended September 30, 2015. The Company highlighted important corporate, commercial, and regulatory updates from the quarter.
Total revenues resulting from VIMOVO® royalties for the three month period ended September 30, 2015, were $5.8 million, compared to total revenues of $7.5 million in the third quarter of 2014 that included $5.5 million of royalties and $2.0 million of amortization of the upfront fee for licensing of YOSPRALA. Total royalty revenues for the third quarter of 2015 increased 12 percent versus the prior quarter and 5 percent from the comparable period in 2014.
Help employers find you! Check out all the jobs and post your resume.
